Trust Size
$4.9B
Peak Price
$517.20
Current Price
$8.00
Return
+54.5%
Price Journey
What Happened
Claritev (formerly MultiPlan) is a healthcare cost management company that provides data analytics-driven solutions to help payers manage the cost of healthcare. It went public via SPAC merger with Churchill Capital Corp VII in 2020 in a $5.7 billion deal. The company generates nearly $1 billion in annual revenue.
Churchill Capital Corp VII merged with MultiPlan in October 2020 at a $5.7 billion valuation. A Muddy Waters short report shortly after caused the stock to crater. The company rebranded to Claritev in 2024, posting $965M in 2025 revenue with $603M adjusted EBITDA. Despite carrying heavy debt from the SPAC transaction, Claritev remains operational and publicly traded, initiating a $75M share buyback in 2026.
Timeline
2020-02-12
S-1 Registration Filed
2020-09-18
Merger Proxy Filed (DEFM14A)
SEC Filing Details
CIK Number
1793229
Total SEC Filings
491
State of Incorporation
DE
Last Filing Date
2026-03-20
Business Location
New York, NY
Trust/Asset Size
$4.9B
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Claritev